Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any osteogenesis imperfecta in which the cause of the disease is a mutation in the SERPINF1 gene.
Features include always present findings: Elevated circulating alkaline phosphatase concentration, Blue sclerae, Motor delay, and Elevated circulating deoxypyridinoline concentration and others. 16 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 6 | Biconcave vertebral bodies, Joint hypermobility, Recurrent fractures |
SERPINF1 function has not been fully characterized.
Osteogenesis imperfecta type 6 is associated with mutations in the SERPINF1 gene on chromosome 17.
Genetic testing for SERPINF1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for osteogenesis imperfecta type 6 has been reported in the published literature.
Phenotype severity distribution: 9 always present features.
3 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 1 PHASE3, 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
14 publications have been identified in PubMed for osteogenesis imperfecta type 6. Research spans Basic Science / Preclinical (29%), Epidemiology / Natural History (29%), and Diagnostic / Biomarker (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 4 |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:26 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Lab test results |
2 |
Elevated circulating alkaline phosphatase concentration, Elevated circulating deoxypyridinoline concentration |
Ears | 1 | Hearing loss (hearing impairment) |
Disease patterns and progression | 4 | 29% |
Testing and diagnosis research | 2 | 14% |
Patient case studies | 2 | 14% |
Research summaries | 1 | 7% |
New treatment approaches | 1 | 7% |
Ozturk FN (2026). [PMID: 42059978](https://pubmed.ncbi.nlm.nih.gov/42059978/). *Arch Osteoporos*. [Epidemiology / Natural History]
Guarnieri V (2026). [PMID: 41171600](https://pubmed.ncbi.nlm.nih.gov/41171600/). *Journal of endocrinological investigation*. [Epidemiology / Natural History]
Badiger VA (2026). [PMID: 41362246](https://pubmed.ncbi.nlm.nih.gov/41362246/). *American journal of medical genetics. Part A*. [Review / Meta-Analysis]
Hoseinbeyki M (2025). [PMID: 41422392](https://pubmed.ncbi.nlm.nih.gov/41422392/). *Iranian biomedical journal*. [Basic Science / Preclinical]
Bayanova M (2025). [PMID: 40175636](https://pubmed.ncbi.nlm.nih.gov/40175636/). *Scientific reports*. [Epidemiology / Natural History]
Selina A (2025). [PMID: 40177331](https://pubmed.ncbi.nlm.nih.gov/40177331/). *Bone reports*. [Diagnostic / Biomarker]
Sait H (2025). [PMID: 40650436](https://pubmed.ncbi.nlm.nih.gov/40650436/). *Clinical genetics*. [Epidemiology / Natural History]
Tian Y (2025). [PMID: 40692043](https://pubmed.ncbi.nlm.nih.gov/40692043/). *Life sciences*. [Case Report / Case Series]
Merkuryeva ES (2025). [PMID: 40649977](https://pubmed.ncbi.nlm.nih.gov/40649977/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Zhou S (2025). [PMID: 40282376](https://pubmed.ncbi.nlm.nih.gov/40282376/). *Genes*. [Basic Science / Preclinical]